Key Product Details
Description: | Akt kinase inhibitor. Antitumor |
Chemical Name: | 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol |
Purity: | ≥98% (HPLC) |
Molecular Weight: | 425.48 |
Customers also Viewed
Customers also Purchased
Citations for GSK 690693 (3)
Citations are publications that use Bio-Techne products. Selected citations for GSK 690693 include:
-
Rogers and Gahring
(2015)
Upregulation of Nicotinic Acetylcholine Receptor α4+β2 through a Ligand-Independent PI3Kβ Mechanism That Is Enhanced by TNFα and the Jak2/p38Mapk Pathways.
J Mol Neurosci.
10:e0143319
PMID: 26619345 -
Sokołowska et al.
(2014)
Orexins protect neuronal cell cultures against hypoxic stress: an involvement of Akt signaling.
Stem Cell Reports.
52:48
PMID: 24243084 -
Khuituan et al.
(2012)
Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D3-enhanced duodenal calcium transport in male mice.
Am J Physiol Endocrinol Metab.
302:E903
PMID: 22275752
There are no citations that match your criteria.
Customer Reviews for GSK 690693 (1)
-
Species: HumanAssay Type: In VitroGSK 690693 inhibitor was used in studies exploring the role of drug-induced activation of Akt kinase in pancreatic cancer cells. Results were consistent.
There are no reviews that match your criteria.